1. Home
  2. ECX vs REPL Comparison

ECX vs REPL Comparison

Compare ECX & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECX
  • REPL
  • Stock Information
  • Founded
  • ECX 2017
  • REPL 2015
  • Country
  • ECX China
  • REPL United States
  • Employees
  • ECX N/A
  • REPL N/A
  • Industry
  • ECX EDP Services
  • REPL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ECX Technology
  • REPL Health Care
  • Exchange
  • ECX Nasdaq
  • REPL Nasdaq
  • Market Cap
  • ECX 674.7M
  • REPL 547.0M
  • IPO Year
  • ECX N/A
  • REPL 2018
  • Fundamental
  • Price
  • ECX $2.29
  • REPL $4.65
  • Analyst Decision
  • ECX Strong Buy
  • REPL Hold
  • Analyst Count
  • ECX 1
  • REPL 9
  • Target Price
  • ECX $3.20
  • REPL $6.67
  • AVG Volume (30 Days)
  • ECX 1.3M
  • REPL 4.7M
  • Earning Date
  • ECX 11-06-2025
  • REPL 11-11-2025
  • Dividend Yield
  • ECX N/A
  • REPL N/A
  • EPS Growth
  • ECX N/A
  • REPL N/A
  • EPS
  • ECX N/A
  • REPL N/A
  • Revenue
  • ECX $756,543,682.00
  • REPL N/A
  • Revenue This Year
  • ECX $817.95
  • REPL N/A
  • Revenue Next Year
  • ECX $29.45
  • REPL N/A
  • P/E Ratio
  • ECX N/A
  • REPL N/A
  • Revenue Growth
  • ECX 3.49
  • REPL N/A
  • 52 Week Low
  • ECX $0.76
  • REPL $2.68
  • 52 Week High
  • ECX $3.25
  • REPL $17.00
  • Technical
  • Relative Strength Index (RSI)
  • ECX 63.56
  • REPL 47.26
  • Support Level
  • ECX $2.08
  • REPL $4.57
  • Resistance Level
  • ECX $2.36
  • REPL $4.95
  • Average True Range (ATR)
  • ECX 0.15
  • REPL 0.33
  • MACD
  • ECX 0.01
  • REPL 0.12
  • Stochastic Oscillator
  • ECX 82.14
  • REPL 83.56

About ECX ECARX Holdings Inc. Ordinary shares

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: